In more recent studies using IL-10 and IL-10 receptor knockout and transgenic mouse strains, investigators reported that IL-10 directly mediated intratumoral activation and expansion of resident tumor-reactive CD8 T cells that independently rejected established tumor growth and progression (Emmerich et al., 2012). This evidence concerns the gene CD8A and neoplasm.